Ionis Pharma (IONS) Tops Q4 EPS by 1c

Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $172.3 million versus the consensus estimate of $124.69 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
• SLM (SLM) Tops Q1 EPS by 20c; offers guidance
• Oceaneering (OII) Tops Q1 EPS by 5c, confirms prior guidance